US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist
  • 2.500
  • -0.070-2.72%
Close Aug 16 16:00 ET
  • 2.500
  • 0.0000.00%
Post 20:02 ET
75.44MMarket Cap-871P/E (TTM)

Relmada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-27.69%18.82M
-18.35%22.99M
-35.69%103.7M
-30.68%26.83M
-41.42%22.69M
-42.81%26.03M
-26.49%28.15M
28.28%161.25M
13.22%38.7M
-9.18%38.74M
Selling and administrative expenses
-34.09%8.1M
-21.23%9.68M
2.02%48.89M
2.06%12.08M
49.10%12.24M
-15.84%12.29M
-7.47%12.29M
36.61%47.93M
32.83%11.83M
-5.22%8.21M
-General and administrative expense
-34.09%8.1M
-21.23%9.68M
2.02%48.89M
2.06%12.08M
49.10%12.24M
-15.84%12.29M
-7.47%12.29M
36.61%47.93M
32.83%11.83M
-5.22%8.21M
Research and development costs
-21.97%10.72M
-16.11%13.31M
-51.64%54.81M
-45.10%14.75M
-65.76%10.45M
-55.55%13.74M
-36.59%15.86M
25.05%113.32M
6.31%26.87M
-10.19%30.53M
Operating profit
27.69%-18.82M
18.35%-22.99M
35.69%-103.7M
30.68%-26.83M
41.42%-22.69M
42.81%-26.03M
26.49%-28.15M
-28.28%-161.25M
-13.22%-38.7M
9.18%-38.74M
Net non-operating interest income expense
-29.37%963.01K
-12.57%1.06M
93.72%5.15M
12.98%1.26M
59.67%1.32M
252.00%1.36M
266.01%1.21M
121.79%2.66M
602.52%1.11M
178.05%827.61K
Non-operating interest income
-29.37%963.01K
-12.57%1.06M
93.72%5.15M
12.98%1.26M
59.67%1.32M
252.00%1.36M
266.01%1.21M
121.79%2.66M
602.52%1.11M
178.05%827.61K
Other net income (expense)
113.70%87.65K
-83.37%103.85K
-115.60%-241.16K
213.60%404.94K
58.20%-630.86K
-112.32%-639.63K
135.11%624.4K
223.92%1.55M
-0.59%-356.47K
-503.17%-1.51M
Gain on sale of security
113.70%87.65K
-83.37%103.85K
94.98%-241.16K
213.60%404.94K
58.20%-630.86K
44.95%-639.63K
135.11%624.4K
-285.27%-4.81M
-0.59%-356.47K
-503.17%-1.51M
Other non- operating income (expenses)
----
----
----
----
----
----
----
--6.35M
--0
----
Income before tax
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
-24.88%-157.04M
-10.37%-37.94M
7.48%-39.42M
Income tax
Net income
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
-24.88%-157.04M
-10.37%-37.94M
7.48%-39.42M
Net income continuous Operations
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
-24.88%-157.04M
-10.37%-37.94M
7.48%-39.42M
Minority interest income
Net income attributable to the parent company
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
-24.88%-157.04M
-10.37%-37.94M
7.48%-39.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
-24.88%-157.04M
-10.37%-37.94M
7.48%-39.42M
Basic earnings per share
29.76%-0.59
17.24%-0.72
38.11%-3.28
34.13%-0.83
44.27%-0.73
36.84%-0.84
37.86%-0.87
25.98%-5.3
30.00%-1.26
46.31%-1.31
Diluted earnings per share
29.76%-0.59
17.24%-0.72
38.11%-3.28
34.13%-0.83
44.27%-0.73
36.84%-0.84
37.86%-0.87
25.98%-5.3
30.00%-1.26
46.31%-1.31
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -27.69%18.82M-18.35%22.99M-35.69%103.7M-30.68%26.83M-41.42%22.69M-42.81%26.03M-26.49%28.15M28.28%161.25M13.22%38.7M-9.18%38.74M
Selling and administrative expenses -34.09%8.1M-21.23%9.68M2.02%48.89M2.06%12.08M49.10%12.24M-15.84%12.29M-7.47%12.29M36.61%47.93M32.83%11.83M-5.22%8.21M
-General and administrative expense -34.09%8.1M-21.23%9.68M2.02%48.89M2.06%12.08M49.10%12.24M-15.84%12.29M-7.47%12.29M36.61%47.93M32.83%11.83M-5.22%8.21M
Research and development costs -21.97%10.72M-16.11%13.31M-51.64%54.81M-45.10%14.75M-65.76%10.45M-55.55%13.74M-36.59%15.86M25.05%113.32M6.31%26.87M-10.19%30.53M
Operating profit 27.69%-18.82M18.35%-22.99M35.69%-103.7M30.68%-26.83M41.42%-22.69M42.81%-26.03M26.49%-28.15M-28.28%-161.25M-13.22%-38.7M9.18%-38.74M
Net non-operating interest income expense -29.37%963.01K-12.57%1.06M93.72%5.15M12.98%1.26M59.67%1.32M252.00%1.36M266.01%1.21M121.79%2.66M602.52%1.11M178.05%827.61K
Non-operating interest income -29.37%963.01K-12.57%1.06M93.72%5.15M12.98%1.26M59.67%1.32M252.00%1.36M266.01%1.21M121.79%2.66M602.52%1.11M178.05%827.61K
Other net income (expense) 113.70%87.65K-83.37%103.85K-115.60%-241.16K213.60%404.94K58.20%-630.86K-112.32%-639.63K135.11%624.4K223.92%1.55M-0.59%-356.47K-503.17%-1.51M
Gain on sale of security 113.70%87.65K-83.37%103.85K94.98%-241.16K213.60%404.94K58.20%-630.86K44.95%-639.63K135.11%624.4K-285.27%-4.81M-0.59%-356.47K-503.17%-1.51M
Other non- operating income (expenses) ------------------------------6.35M--0----
Income before tax 29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M-24.88%-157.04M-10.37%-37.94M7.48%-39.42M
Income tax
Net income 29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M-24.88%-157.04M-10.37%-37.94M7.48%-39.42M
Net income continuous Operations 29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M-24.88%-157.04M-10.37%-37.94M7.48%-39.42M
Minority interest income
Net income attributable to the parent company 29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M-24.88%-157.04M-10.37%-37.94M7.48%-39.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M-24.88%-157.04M-10.37%-37.94M7.48%-39.42M
Basic earnings per share 29.76%-0.5917.24%-0.7238.11%-3.2834.13%-0.8344.27%-0.7336.84%-0.8437.86%-0.8725.98%-5.330.00%-1.2646.31%-1.31
Diluted earnings per share 29.76%-0.5917.24%-0.7238.11%-3.2834.13%-0.8344.27%-0.7336.84%-0.8437.86%-0.8725.98%-5.330.00%-1.2646.31%-1.31
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg